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Abstract: The inhabitants of Lazio, similarly to those of other Italian regions, have been historically
exposed to the detrimental effects of an inadequate intake of iodine. The latter is a micronutrient
essential for the biosynthesis of thyroid hormones (TH). Iodine deficiency is responsible for a number
of adverse effects on human health known as iodine deficiency disorders (IDD), the most common of
which worldwide are goiter and hypothyroidism. In order to reduce IDD, a national salt iodination
program was started in Italy in 2005. In this article we reviewed the available data regarding iodine
intake in the Lazio population before and after the introduction of the national salt iodination
program, in order to evaluate its efficacy and the eventual problem(s) limiting its success. On the
whole, the information acquired indicates that, following the introduction of the program, the dietary
iodine intake in the Lazio population is improved. There is, however, still much work ahead to
ameliorate the iodine prophylaxis in this region. In fact, although a generally adequate iodine intake
in school-age children has been observed, there are still areas where a mild iodine insufficiency is
present. Moreover, two independent epidemiological surveys on pregnant women evidenced a low
urinary iodine concentration with respect to the reference range conceived by the World Health
Organization. These findings demonstrate the need for greater attention to the iodine prophylaxis by
health care providers (i.e., obstetricians, gynecologists, pediatricians, etc.), and the implementation of
effective advertising campaigns aimed at increasing the knowledge and awareness of the favorable
effects of iodine supplementation on population health.
Keywords: iodine deficiency; schoolchildren; pregnancy; iodine prophylaxis; iodine deficiency
disorders; goiter; hypothyroidism
1. Introduction
Iodine is an indispensable micronutrient required by the thyroid gland for the appropriate
synthesis of the thyroid hormones (TH), i.e., triiodothyronine (T3) and its prohormone thyroxine (T4) [1].
By modulating key cellular processes (i.e., proliferation, differentiation, apoptosis, and metabolism),
TH affect multiple body tasks from the early stages of prenatal life, when maternal thyroxinemia plays a
fundamental role in neural growth and differentiation, to adulthood, in which they regulate metabolism,
thermogenesis, feeding, memory/learning abilities, and cardiovascular and reproductive functions [2–5].
To guarantee an appropriate TH biosynthesis, the daily dietary iodine intake recommended by the
World Health Organization (WHO), the United Nations Children’s Emergency Fund (UNICEF), and the
International Council for the Control of Iodine Deficiency Disorders (ICCIDD) is 90 µg for preschool
children (0 to 59 months), 120 µg for schoolchildren (6 to 12 years), 150 µg for adolescents (above
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12 years) and adults, 250 µg for pregnant and lactating women [6]. Failure to meet these requirements is
held responsible for a number of adverse effects on human health known as iodine deficiency disorders
(IDD) [7]. These affect almost 1.9 billion people worldwide and constitute a major public health issue
in different countries, including Italy [6,8,9]. IDD may occur at all ages, from the early stages of fetal
life to adulthood. Of particular relevance are the detrimental effects of an insufficient maternal intake
of iodine on development and maturation of the fetal brain, which represents a foremost preventable
cause of mental defects [10]. Further adverse effects include abortion, stillbirth, impairment of cognitive
functions, delayed growth and puberty, hypothyroidism, goiter, and infertility [11–17].
The epidemiological criteria established by the WHO to evaluate the prevalence and severity
of iodine deficiency in a specific population refer to the median urinary iodine concentration (UIC)
in morning spot urine samples, along with the presence of goiter [6]. Assuming a daily diuresis of
1.5 liters, a given land area is considered iodine sufficient when the median UIC of the population is
comprised between 100 and 199 µg/L, and goiter prevalence in school-age children (≥6 years) is below
5% [6]. In pregnant women, median UIC should be comprised between 150 and 250 µg/L to guarantee
normal fetal development. Reported in Table 1 are the WHO reference values of UIC for classifying the
iodine status in a population.
Table 1. Median urinary iodine concentrations (UIC) and iodine status in school-age children and
pregnant women according to the World Health Organization (see reference [6]).
School-Age Children Pregnant Women
UIC (µg/L) Iodine Status UIC (µg/L) Iodine Status
<20 Severe iodine deficiency <150 Insufficient
20–49 Moderate iodine deficiency 150–249 Adequate
50–99 Mild iodine deficiency 250–499 Above requirements
100–199 Adequate iodine nutrition ≥500 Excessive
200–299 More than adequate
≥300 Excessive
In the attempt to establish an efficient iodine prophylaxis and to eradicate IDD, the law n.55/2005,
introducing a national salt iodination program (30 mg of potassium iodate per kilogram of salt),
was promulgated in 2005 in Italy [9]. The rules laid down by this law make the sale of iodized salt
compulsory and favor the silent prophylaxis. Specifically, the sale points of salt for direct consumption
have to expose iodine enriched salt while ensuring the availability of non-iodized salt, which is
provided only upon specific request of the consumer. In the public catering sector, such as bars and
restaurants, and in workplace or community canteens, iodine-enriched salt should also be available
to consumers. Furthermore, the law recommends the use of iodized salt in the food industries as an
ingredient in preparation and food storage [9].
In the present manuscript, we will review the available information on iodine status in Lazio
(a region of central Italy) before and after the introduction of the Italian law n.55/2005, along with the
encountered problems hampering the actuation of the national iodine prophylaxis program. All papers
analyzed have been obtained from PubMed. Additional data are from the National Observatory for
the Monitoring of Iodoprophylaxis in Italy (OSNAMI) of the Italian National Institute of Health.
2. Iodine Status in the Lazio Region before the Introduction of the National Iodine
Prophylaxis Program
The Italian population, including the inhabitants of Lazio, has historically been exposed to the
negative effects of iodine food shortages [9,18–20].
In the seventies of the last century, epidemiological studies carried out in about 5700 school-age
children (6–13 years old) of southern Lazio documented the presence of iodine deficiency [21]. Reported
mean UIC values varied from 22 µg per gram of creatinine (µg/g Cr) to 40 µg/g Cr, consistent with an
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iodine deficiency of moderate degree, as shown in Figure 1 and Table 1. In these children the prevalence
of goiter, evaluated by palpation, varied from 6.9% to 11.7%, as shown in Figure 1. In a subsequent
case study, performed in 1998 in the city of Rome, UIC and goiter prevalence were investigated in
1040 school-age children (6–14 years old) [22]. A median UIC value of 92 µg/L (mean UIC value of
98 µg/L), consistent with a mild iodine deficiency, as shown in Table 1, was still observed, as shown
in Figure 1. On the other hand, goiter prevalence determined by ultrasound was 4.7% [22]. Hence,
before the introduction of the nationwide iodine prophylaxis program, the data collected indicated
a condition of mild to moderate iodine deficiency of children residing in Lazio. To the best of our
knowledge, no studies were performed on iodine status in pregnant women before 2005.
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Figure 1. Urinary iodine concentrations (UIC) and goiter prevalence in the inhabitants of Lazio before
(A) and after (B) the introduction of the national salt iodination program.
3. Iodine Status in the Lazio Region after the Introduction of the National Iodine
Prophylaxis Program
Following the introduction of the iodine prophylaxis program, three independent studies were
performed in order to assess iodine status in both school-age children and pregnant women [23–25].
A first observational study was realized in 2006 in the city of Rome to evaluate iodine intake in
pregnant women compared to non-pregnant age-matched ones [23]. The study enrolled 51 clinically
healthy pregnant women in their first gestational trimester, and 100 clinically healthy non-pregnant
women [23]. The median UIC value observed in control women was 182µg/L, suggestive of an adequate
iodine intake, as shown in Figure 1. However, pregnant women showed poor iodine consumption,
attested by a median UIC value of 74 µg/L. In particular, the UIC was found below the normal range
only in 4% of control women but in 92% of pregnant women. These observations pointed out that,
Nutrients 2019, 11, 1647 4 of 7
despite the iodine sufficiency recognized in control women, the majority of pregnant women and their
fetuses were exposed to detrimental consequences of iodine deficiency.
After that, a new survey was performed in 2015 in the city of Cassino, located in the south of
Lazio, whose residents were previously found to have a moderate iodine deficiency, as shown in
Figure 1B [24]. In this study, UIC and thyroid volume measured by ultrasonography were evaluated in
234 school-age children (13–14 years old). At the same time an inquiry was conducted to estimate the
percentage of iodized salt sold in the preceding year by the major local retailers. The latter showed
only 42% of all salt sold in 2014 in this city was iodized. Despite that, a median UIC of 134 µg/L was
observed in the school children under examination, suggesting an adequate iodine intake. This result
was also corroborated by the low prevalence of goiter, encountered only in 3.8% of subjects. However,
when children were grouped based on the regular consumption of iodized salt or milk or both, those
referring no consumption of either iodized salt or milk had a median UIC value (96.4 µg/L), compatible
with a mild iodine deficiency. On the other hand, optimal median UIC values were found in school
children regularly taking either iodized salt (132.1 µg/L) or milk (131 µg/L) or both (147.9 µg/L).
Such evidence strengthens the importance of eating iodized salt and iodine-rich food to achieve the
right amount of iodine in the body for thyroid function [24].
A further study was aimed to analyze iodine intake in pregnant women from the same area of
Cassino [25]. Study participants were enrolled in the period from January 2016 to April 2017, for a total
of 96 pregnant women and 79 age-matched non-pregnant women. In the control group, median UIC
was nearby 98 µg/L, consistent with a mild iodine deficiency, while pregnant women had a median UIC
of about 110 µg/L, below the lower value (150 µg/L) recommended by the WHO for categorizing iodine
adequacy in a pregnant population. In agreement with this finding, a significantly increased thyroid
volume was recorded in pregnant women compared to non-pregnant ones, as shown in Figure 1 [25].
In this study the effects of iodized salt and/or milk consumption on UIC levels of both control and
pregnant women, considered as a whole, were also examined. The analysis showed an increasing
trend of UIC from women not using either iodized salt or milk (median UIC 79.8 µg/L) compared to
those using iodized salt (median UIC 94 µg/L) or milk (median UIC 112 µg/L) or both (median UIC
118 µg/L) [25]. Thus, once again the data obtained highlight the need to implement the national salt
iodination program, as well as the importance of inserting initiatives targeted at control of iodine
prophylaxis and prevention of IDD in regional health plans. It has to be mentioned, however, that the
aforementioned studies rely on a limited number of subjects analyzed and should be corroborated on
larger case studies.
4. Encountered Problems Hampering the Actuation of the National Iodine Prophylaxis Program
As reported above, the available epidemiological data demonstrated that, following the
introduction of the national salt iodination program, the iodine intake in the inhabitants of Lazio is
somewhat improved. However, prevention measures are still needed to fully avoid the risks of IDD in
this region. In particular, there are three main lines of action that should be pursued.
The first is devising strategies to increment the amount of iodized salt sold by retailers. In fact,
due to the lack of penalties related to non-compliance with the law n.55/2005, vendors are not
discouraged from exhibiting non-iodized salt on store shelves, and they sell both iodized salt and
or even just non-iodized salt [24]. This, at least in part, may explain the low percentage of iodized
salt sold (42%) in the city of Cassino, and why 45% of the school children and 50% of women of
child-bearing age do not use iodized salt. Moreover, the latest data provided by OSNAMI indicated
that the percentage of iodized salt used in collective catering is still very low (about 24%), and that
used by the food industry is even lower (3–8%) [26]. Thus, it is of great importance to encourage this
manufacturing sector to make more extensive use of iodized salt.
The second line of intervention should be to adequately inform the population on the beneficial
effects on human health deriving from the consumption of iodized salt. This task could be accomplished
by creating effective advertising campaigns able to reach every single citizen. In this context, an initiative
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of the Ministry of Health is taking place that aims to provide all students with comprehensive
information about the beneficial effects of the use of iodized salt through meetings with medical staff
organized by individual schools [27].
Finally, greater attention by the major health care providers of the National Health System is highly
desirable, especially obstetricians, gynecologists, and pediatricians. Different surveys, in fact, noticed
that obstetricians and midwives do not recommend iodine supplementation either to women planning
pregnancy or during pregnancy or lactation [28,29]. To this regard, a position statement on the use of
iodized salt in adulthood and children was signed by the Italian Ministry of Health, the National Institute
of Health, the Italian Society of Endocrinology, the Italian Thyroid Association, the Medical Association
of Endocrinologists, the Italian Society of Pediatric Endocrinology and Diabetology, the Italian Society
of Pediatrics, the Italian Society of Gynecology and Obstetrics, the Italian Association of Consultative
Gynecologists, the Italian Society of Human Nutrition, the Italian Society of Nutraceuticals, the Italian
Association of Dietetics and Clinical Nutrition, the Italian Society for the Study of Food Behavior
Disorders, the Italian Federation of Nutrition, and the National Federation of General Practitioners [30].
The joint implementation of all these actions should provide a consistent contribution toward the
eradication of iodine deficiency in Italy.
5. Conclusions
The available epidemiological data indicate that, following the introduction of the national salt
iodination program, the iodine intake of the inhabitants of Lazio has only partially improved. In fact,
although a generally adequate iodine intake in school-age children has been observed, pregnant women
still show an iodine deficiency. Thus, it is necessary to encourage compliance with the law in order
to reach optimal iodine nutrition and to completely eradicate the IDD in this region. The situation
recorded in Lazio corroborates the recent Krakow Declaration on Iodine reporting an increased concern
about the fading commitment of policymakers to address iodine deficiency in Europe and the poor
attention of policymakers, opinion leaders, and the public toward the resolution of IDD [31]. Thus, it has
become of primary importance to join forces with policymakers, public health officials, and scientists
to guarantee that existing European strategies to prevent IDD are fulfilled and implemented.
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